Showing results (461-470 of 482) with videos related to

Sort By:
Pageof 49
Hepatology (Baltimore, Md.)|March 29, 2021
Risk of HCC With Hepatitis B Viremia Among HIV/HBV-Coinfected Persons in North AmericaH Nina Kim, Craig W Newcomb, Dean M Carbonari, et al.
The New England Journal of Medicine|April 15, 2014
Ledipasvir and sofosbuvir for previously treated HCV genotype 1 infectionNezam Afdhal, K Rajender Reddy, David R Nelson, et al.
The New England Journal of Medicine|April 12, 2014
Ledipasvir and sofosbuvir for 8 or 12 weeks for chronic HCV without cirrhosisKris V Kowdley, Stuart C Gordon, K Rajender Reddy, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 15, 2026
REACT Score, a Novel Scoring System, Improves the Prediction of Non-Elective Readmissions in Patients With Decompensated CirrhosisYolanda Sánchez-Torrijos, Ana Torres-Domínguez, Isabel Carmona, et al.
The American Journal of Gastroenterology|June 22, 2016
Lower Observed Hepatocellular Carcinoma Incidence in Chronic Hepatitis B Patients Treated With Entecavir: Results of the ENUMERATE StudyJoseph Ahn, Joseph K Lim, Hannah M Lee, et al.
Nature Medicine|February 9, 2026
Extracorporeal liver cross-circulation using transgenic xenogeneic pig livers with brain-dead human decedentsAbraham Shaked, Alex Sagar, Kim M Olthoff, et al.
Hepatology (Baltimore, Md.)|July 13, 2021
A Pragmatic, Randomized Controlled Trial of Oral Antivirals for the Treatment of Chronic Hepatitis C: The PRIORITIZE StudyMark S Sulkowski, Juhi S Moon, Kenneth E Sherman, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|February 19, 2016
Daclatasvir combined with sofosbuvir or simeprevir in liver transplant recipients with severe recurrent hepatitis C infectionRobert J Fontana, Robert S Brown, Ana Moreno-Zamora, et al.
Pageof 49